Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Quantitative Oculomotor Assessment in Hereditary Ataxia: Systematic Review and Consensus by the Ataxia Global Initiative Working Group on Digital-motor Biomarkers

P. Garces, CA. Antoniades, A. Sobanska, N. Kovacs, SH. Ying, AS. Gupta, S. Perlman, DJ. Szmulewicz, C. Pane, AH. Németh, LB. Jardim, G. Coarelli, M. Dankova, A. Traschütz, AA. Tarnutzer

. 2024 ; 23 (3) : 896-911. [pub] 20230428

Language English Country United States

Document type Systematic Review, Journal Article

E-resources Online Full text

NLK ProQuest Central from 2002-03-01 to 1 year ago
Medline Complete (EBSCOhost) from 2002-01-01 to 1 year ago
Nursing & Allied Health Database (ProQuest) from 2002-03-01 to 1 year ago
Health & Medicine (ProQuest) from 2002-03-01 to 1 year ago

Oculomotor deficits are common in hereditary ataxia, but disproportionally neglected in clinical ataxia scales and as outcome measures for interventional trials. Quantitative assessment of oculomotor function has become increasingly available and thus applicable in multicenter trials and offers the opportunity to capture severity and progression of oculomotor impairment in a sensitive and reliable manner. In this consensus paper of the Ataxia Global Initiative Working Group On Digital Oculomotor Biomarkers, based on a systematic literature review, we propose harmonized methodology and measurement parameters for the quantitative assessment of oculomotor function in natural-history studies and clinical trials in hereditary ataxia. MEDLINE was searched for articles reporting on oculomotor/vestibular properties in ataxia patients and a study-tailored quality-assessment was performed. One-hundred-and-seventeen articles reporting on subjects with genetically confirmed (n=1134) or suspected hereditary ataxia (n=198), and degenerative ataxias with sporadic presentation (n=480) were included and subject to data extraction. Based on robust discrimination from controls, correlation with disease-severity, sensitivity to change, and feasibility in international multicenter settings as prerequisite for clinical trials, we prioritize a core-set of five eye-movement types: (i) pursuit eye movements, (ii) saccadic eye movements, (iii) fixation, (iv) eccentric gaze holding, and (v) rotational vestibulo-ocular reflex. We provide detailed guidelines for their acquisition, and recommendations on the quantitative parameters to extract. Limitations include low study quality, heterogeneity in patient populations, and lack of longitudinal studies. Standardization of quantitative oculomotor assessments will facilitate their implementation, interpretation, and validation in clinical trials, and ultimately advance our understanding of the evolution of oculomotor network dysfunction in hereditary ataxias.

Balance Disorders and Ataxia Service Royal Victoria Eye and Ear Hospital East Melbourne Melbourne VIC 3002 Australia

Departamento de Medicina Interna Universidade Federal do Rio Grande do Sul Porto Alegre Brazil

Department of Genetics Neurogene National Reference Centre for Rare Diseases Pitié Salpêtrière University Hospital Assistance Publique Hôpitaux de Paris Paris France

Department of Neurology Centre of Hereditary Ataxias 2nd Faculty of Medicine Charles University and Motol University Hospital Prague Czech Republic

Department of Neurology Massachusetts General Hospital Harvard Medical School Boston MA USA

Department of Neurology University of Pécs Medical School Pécs Hungary

Department of Neurosciences and Reproductive and Odontostomatological Sciences University of Naples Federico 2 Naples Italy

Department of Otology and Laryngology and Department of Neurology Harvard Medical School Boston MA USA

Faculty of Medicine University of Zurich Zurich Switzerland

German Center for Neurodegenerative Diseases University of Tübingen Tübingen Germany

Institute of Psychiatry and Neurology Warsaw Poland

Neurology Cantonal Hospital of Baden 5404 Baden Switzerland

NeuroMetrology Lab Nuffield Department of Clinical Neurosciences Clinical Neurology Medical Sciences Division University of Oxford Oxford OX3 9DU UK

Nuffield Department of Clinical Neurosciences University of Oxford Oxford UK

Oxford Centre for Genomic Medicine Oxford University Hospitals NHS Trust Oxford UK

Research Division Translational Genomics of Neurodegenerative Diseases Hertie Institute for Clinical Brain Research and Center of Neurology University of Tübingen Tübingen Germany

Roche Pharma Research and Early Development Neuroscience and Rare Diseases Roche Innovation Center Basel Basel Switzerland

Serviço de Genética Médica Centro de Pesquisa Clínica e Experimental Hospital de Clínicas de Porto Alegre Porto Alegre Brazil

Sorbonne Université Institut du Cerveau Paris Brain Institute ICM Inserm U1127 CNRS UMR7225 Paris France

The Florey Institute of Neuroscience and Mental Health Parkville Melbourne VIC 3052 Australia

University of California Los Angeles Los Angeles California USA

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013826
003      
CZ-PrNML
005      
20240905133904.0
007      
ta
008      
240725s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12311-023-01559-9 $2 doi
035    __
$a (PubMed)37117990
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Garces, Pilar $u Roche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland
245    10
$a Quantitative Oculomotor Assessment in Hereditary Ataxia: Systematic Review and Consensus by the Ataxia Global Initiative Working Group on Digital-motor Biomarkers / $c P. Garces, CA. Antoniades, A. Sobanska, N. Kovacs, SH. Ying, AS. Gupta, S. Perlman, DJ. Szmulewicz, C. Pane, AH. Németh, LB. Jardim, G. Coarelli, M. Dankova, A. Traschütz, AA. Tarnutzer
520    9_
$a Oculomotor deficits are common in hereditary ataxia, but disproportionally neglected in clinical ataxia scales and as outcome measures for interventional trials. Quantitative assessment of oculomotor function has become increasingly available and thus applicable in multicenter trials and offers the opportunity to capture severity and progression of oculomotor impairment in a sensitive and reliable manner. In this consensus paper of the Ataxia Global Initiative Working Group On Digital Oculomotor Biomarkers, based on a systematic literature review, we propose harmonized methodology and measurement parameters for the quantitative assessment of oculomotor function in natural-history studies and clinical trials in hereditary ataxia. MEDLINE was searched for articles reporting on oculomotor/vestibular properties in ataxia patients and a study-tailored quality-assessment was performed. One-hundred-and-seventeen articles reporting on subjects with genetically confirmed (n=1134) or suspected hereditary ataxia (n=198), and degenerative ataxias with sporadic presentation (n=480) were included and subject to data extraction. Based on robust discrimination from controls, correlation with disease-severity, sensitivity to change, and feasibility in international multicenter settings as prerequisite for clinical trials, we prioritize a core-set of five eye-movement types: (i) pursuit eye movements, (ii) saccadic eye movements, (iii) fixation, (iv) eccentric gaze holding, and (v) rotational vestibulo-ocular reflex. We provide detailed guidelines for their acquisition, and recommendations on the quantitative parameters to extract. Limitations include low study quality, heterogeneity in patient populations, and lack of longitudinal studies. Standardization of quantitative oculomotor assessments will facilitate their implementation, interpretation, and validation in clinical trials, and ultimately advance our understanding of the evolution of oculomotor network dysfunction in hereditary ataxias.
650    _2
$a lidé $7 D006801
650    12
$a konsensus $7 D032921
650    _2
$a poruchy hybnosti oka $x diagnóza $x patofyziologie $x genetika $7 D015835
650    _2
$a pohyby očí $x fyziologie $7 D005133
650    _2
$a biologické markery $7 D015415
655    _2
$a systematický přehled $7 D000078182
655    _2
$a časopisecké články $7 D016428
700    1_
$a Antoniades, Chrystalina A $u NeuroMetrology Lab, Nuffield Department of Clinical Neurosciences, Clinical Neurology, Medical Sciences Division, University of Oxford, Oxford, OX3 9DU, UK
700    1_
$a Sobanska, Anna $u Institute of Psychiatry and Neurology, Warsaw, Poland
700    1_
$a Kovacs, Norbert $u Department of Neurology, University of Pécs, Medical School, Pécs, Hungary
700    1_
$a Ying, Sarah H $u Department of Otology and Laryngology and Department of Neurology, Harvard Medical School, Boston, MA, USA
700    1_
$a Gupta, Anoopum S $u Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
700    1_
$a Perlman, Susan $u University of California Los Angeles, Los Angeles, California, USA
700    1_
$a Szmulewicz, David J $u Balance Disorders and Ataxia Service, Royal Victoria Eye and Ear Hospital, East Melbourne, Melbourne, VIC, 3002, Australia $u The Florey Institute of Neuroscience and Mental Health, Parkville, Melbourne, VIC, 3052, Australia
700    1_
$a Pane, Chiara $u Department of Neurosciences and Reproductive and Odontostomatological Sciences, University of Naples "Federico II", Naples, Italy
700    1_
$a Németh, Andrea H $u Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK $u Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Trust, Oxford, UK
700    1_
$a Jardim, Laura B $u Departamento de Medicina Interna, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil $u Serviço de Genética Médica/Centro de Pesquisa Clínica e Experimental, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
700    1_
$a Coarelli, Giulia $u Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm U1127, CNRS UMR7225, Paris, France $u Department of Genetics, Neurogene National Reference Centre for Rare Diseases, Pitié-Salpêtrière University Hospital, Assistance Publique, Hôpitaux de Paris, Paris, France
700    1_
$a Dankova, Michaela $u Department of Neurology, Centre of Hereditary Ataxias, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
700    1_
$a Traschütz, Andreas $u Research Division "Translational Genomics of Neurodegenerative Diseases", Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany $u German Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Tübingen, Germany
700    1_
$a Tarnutzer, Alexander A $u Neurology, Cantonal Hospital of Baden, 5404, Baden, Switzerland. alexander.tarnutzer@access.uzh.ch $u Faculty of Medicine, University of Zurich, Zurich, Switzerland. alexander.tarnutzer@access.uzh.ch
773    0_
$w MED00007845 $t Cerebellum $x 1473-4230 $g Roč. 23, č. 3 (2024), s. 896-911
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37117990 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905133858 $b ABA008
999    __
$a ok $b bmc $g 2143565 $s 1225692
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 23 $c 3 $d 896-911 $e 20230428 $i 1473-4230 $m Cerebellum $n Cerebellum $x MED00007845
LZP    __
$a Pubmed-20240725

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...